Rates of prostate cancer cases and deaths have declined or stabilized in many countries. And the United States had the largest recent decrease in disease incidence, a new study says. The findings confirm the benefits of prostate-specific antigen (PSA) screening. It was noted that in the United States, incidence rates rose from the 1980s to the early 1990s, then declined from the mid-2000s through 2015, largely due to increased use of PSA screening.
To read the full article: https://bit.ly/2uMmcDu